Skip to main content

7 in 7 healthcare insights: from Bell Potter’s Healthcare conference in Sorrento

Bell Direct
March 18, 2025

Our Market Analyst, Grady Wulff, recently had the opportunity of attending Bell Potter’s Healthcare Conference in Sorrento, Melbourne, where they engaged in in-depth discussions with seven executives from some of Australia’s most promising emerging healthcare companies.

View the full interviews below:

  1. From the Helm: QBiotics Group Limited General Counsel, Ebru Davidson
  2. From the helm: Clarity Pharmaceuticals (ASX:CU6), Executive Chairperson, Alan Taylor
  3. From the helm: Orthocell Limited (ASX:OCC), CEO & Managing Director, Paul Anderson
  4. From the helm: Neuren Pharmaceuticals (ASX:NEU), Chief Executive Officer, Jon Pilcher
  5. From the helm: EBR Systems (ASX:EBR), CEO & President, John McCutcheon
  6. From the helm: Imugene (ASX:IMU) CEO & Managing Director, Leslie Chong
  7. From the helm: Immutep (ASX:IMM) CEO & Managing Director, Marc Voigt

Superannuation Reforms

Bell Direct
January 16, 2017

Market Update

Julia Lee
January 16, 2017

Market Update

Julia Lee
January 13, 2017

Market Update 12 Jan

Julia Lee
January 12, 2017

Market Update

Julia Lee
January 11, 2017

Market Update

Julia Lee
January 9, 2017

Market Update

Julia Lee
January 6, 2017

Market Update

Julia Lee
January 5, 2017

Market Update

Julia Lee
December 23, 2016

Market Update

Julia Lee
December 22, 2016